ProPhase Labs, Inc.

NasdaqCM:PRPH Stok Raporu

Piyasa değeri: US$40.8m

ProPhase Labs Gelecekteki Büyüme

Future kriter kontrolleri 2/6

ProPhase Labs kazanç ve gelirinin sırasıyla yıllık 69.9% ve 73.1% oranında artması tahmin edilirken, EPS'nin yıllık 37.6% oranında büyümesi bekleniyor.

Anahtar bilgiler

69.9%

Kazanç büyüme oranı

37.6%

EPS büyüme oranı

Pharmaceuticals kazanç büyümesi23.7%
Gelir büyüme oranı73.1%
Gelecekteki özkaynak getirisin/a
Analist kapsamı

Low

Son güncelleme27 Aug 2024

Gelecekteki son büyüme güncellemeleri

Recent updates

Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower

Jul 03
Market Cool On ProPhase Labs, Inc.'s (NASDAQ:PRPH) Revenues Pushing Shares 26% Lower

Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?

Mar 04
Does This Valuation Of ProPhase Labs, Inc. (NASDAQ:PRPH) Imply Investors Are Overpaying?

ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry

Jan 09
ProPhase Labs, Inc.'s (NASDAQ:PRPH) Business And Shares Still Trailing The Industry

ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Sep 21
ProPhase Labs, Inc. (NASDAQ:PRPH) Shares Could Be 28% Above Their Intrinsic Value Estimate

Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt

Aug 11
Here's Why ProPhase Labs (NASDAQ:PRPH) Can Afford Some Debt

We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease

Apr 07
We Ran A Stock Scan For Earnings Growth And ProPhase Labs (NASDAQ:PRPH) Passed With Ease

ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly

Jan 24
ProPhase Labs (NASDAQ:PRPH) Seems To Use Debt Quite Sensibly

ProPhase Labs: Small Cap Stock With Strong Fundamentals And Growth Potential

Oct 13

ProPhase Labs Q2 2022 Earnings Preview

Aug 10

We Think ProPhase Labs (NASDAQ:PRPH) Can Stay On Top Of Its Debt

Jul 26
We Think ProPhase Labs (NASDAQ:PRPH) Can Stay On Top Of Its Debt

ProPhase Labs to license two investigational cancer compounds from Global BioLife

Jul 21

ProPhase Labs: A Stellar Quarter And Another Special Dividend

May 16

ProPhase Labs (NASDAQ:PRPH) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Apr 08
ProPhase Labs (NASDAQ:PRPH) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

ProPhase Labs (NASDAQ:PRPH) Is Using Debt Safely

Mar 23
ProPhase Labs (NASDAQ:PRPH) Is Using Debt Safely

Rock star Growth Puts ProPhase Labs (NASDAQ:PRPH) In A Position To Use Debt

Nov 30
Rock star Growth Puts ProPhase Labs (NASDAQ:PRPH) In A Position To Use Debt

As Employer Vaccine Mandates Fail, Prophase Labs Could Benefit

Oct 20

Calculating The Fair Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)

Jul 22
Calculating The Fair Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)

ProPhase Labs Is A Potential Pure Play On Worries About The Delta And Delta Plus Covid-19 Variants

Jun 28

Here's Why Shareholders May Consider Paying ProPhase Labs, Inc.'s (NASDAQ:PRPH) CEO A Little More

May 14
Here's Why Shareholders May Consider Paying ProPhase Labs, Inc.'s (NASDAQ:PRPH) CEO A Little More

ProPhase Labs partners with Dutchess County New York to provide COVID-19 testing

May 06

A Look At The Intrinsic Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)

Apr 12
A Look At The Intrinsic Value Of ProPhase Labs, Inc. (NASDAQ:PRPH)

Kazanç ve Gelir Büyüme Tahminleri

NasdaqCM:PRPH - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (USD Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/2026956N/AN/A1
12/31/202550-16N/AN/A1
12/31/202415-24N/AN/A1
6/30/202418-26-18-15N/A
3/31/202429-24-21-17N/A
12/31/202344-17-15-11N/A
9/30/202363-10-14-10N/A
6/30/202379-4-6-3N/A
3/31/202394759N/A
12/31/2022123182529N/A
9/30/2022146312123N/A
6/30/2022131271315N/A
3/31/2022111181315N/A
12/31/2021796-18-14N/A
9/30/202139-5-21-16N/A
6/30/202133-2-16-11N/A
3/31/2021280-16-11N/A
12/31/202015-2-4-3N/A
9/30/202012-234N/A
6/30/202011-233N/A
3/31/20209-3-2-2N/A
12/31/201910-3-1-1N/A
9/30/201911-3-1-1N/A
6/30/201911-4-2-2N/A
3/31/201912-3-1-1N/A
12/31/201813-2-2-2N/A
9/30/201813-1-3-3N/A
6/30/201814-1-2-2N/A
3/31/201813-1N/A-6N/A
12/31/201710-2N/A-3N/A
9/30/20176-3N/A-1N/A
6/30/20175-3N/A-1N/A
3/31/20174-3N/A2N/A
12/31/20164-4N/A0N/A
9/30/2016-6-3N/A-2N/A
6/30/2016-3-2N/A-4N/A
3/31/2016-2-2N/A-5N/A
12/31/20153-2N/A-3N/A
9/30/201521-3N/A-4N/A
6/30/201522-7N/A-3N/A
3/31/201522-8N/A-4N/A
12/31/201422-8N/A-3N/A
9/30/201423-7N/A-1N/A
6/30/201424-2N/A-1N/A
3/31/201424-1N/A0N/A
12/31/2013250N/A1N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: PRPH önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Kazançlar ve Piyasa: PRPH önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Yüksek Büyüme Kazançları: PRPH önümüzdeki 3 yıl boyunca kârsız kalmaya devam edeceği tahmin ediliyor.

Gelir ve Pazar: PRPH şirketinin gelirinin (yıllık 73.1% ) US pazarından (yıllık 8.9% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: PRPH şirketinin gelirinin (yıllık 73.1% ) yıllık 20% dan daha hızlı büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: PRPH 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok


Büyüyen şirketleri keşfedin